man cancers. Science 304:554.2. Kang S, Bader AG, Vogt PK Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102:802�?07.3. Ikenoue T, et al. Functional SB939 analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65:4562�?567.4. Isakoff SJ, et al. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res 65:10992�?1000.5. Zhao JJ, et al. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc Natl Acad Sci USA 102:18443�?8448.6. Samuels Y, Ericson K Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18: 77�?2.7. Bader AG, Kang S, Vogt PK Cancer-specific mutations in PIK3CA are oncogenic in vivo.
Proc Natl Acad Sci USA 103:1475�?479.8. Zhao L, Vogt PK Class I PI3K in oncogenic cellular transformation. Y-27632 Oncogene 27: 5486�?496.9. Shekar SC, et al. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit. J Biol Chem 280:27850�?7855.10. Jücker M, et al. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkins lymphoma-derived cell line. Leukemia 16:894�?01.11. Philp AJ, et al. The phosphatidylinositol 3�?kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61:7426�?429.12. Mizoguchi M, Nutt CL, Mohapatra G, Louis DN Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas. Brain Pathol 14:372�?77.13. Jimenez C, et al.
Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17:743�?53.14. Wood LD, et al. The genomic landscapes of human breast and colorectal cancers. Science 318:1108�?113.15. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061�?068.16. Parsons DW, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807�?812.17. Jaiswal BS, et al. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 16:463�?74.18. Huang CH, et al. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 318:1744�?748.19. Wu H, et al.
Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Proc Natl Acad Sci USA 106:20258�?0263.20. Miled N, et al. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317:239�?42.21. Hughes SH, Vogt PK, Stubblefield E, Bishop JM, Varmus HE Integration of avian sarcoma virus DNA in chicken cells. Virology 108:208�?21.22. Oh J, Julias JG, Ferris AL, Hughes SH Construction and characterization of a replication-competent retroviral shuttle vector plasmid. J Virol 76:1762�?768.23. Kang S, Denley A, Vanhaesebroeck B, Vogt PK Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103:1289�?294.
24. Zhao L, Vogt PK Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci USA 105:2652�?657.25. Huang CH, Mandelker D, Gabelli SB, Amzel LM Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. Cell Cycle 7: 1151�?156.26. Fu Z, Aronoff-Spencer E, Wu H, Gerfen GJ, Backer JM The iSH2 domain of PI 3-kinas